In an effort to improve adherence and remove the burden of treatment for patients with type 2 diabetes, researchers examined the efficacy and safety of a new once-a-week injectable insulin.
A recent study examined the association between insulin resistance and cognitive performance and decline in patients with heart disease with and without diabetes.
